Achieving the End: One Year and Counting

In AVAC Report 2012, Achieving the End: One Year and Counting we’ve identified five priorities for action.

Ants Can Kill the Elephant

The following is excerpted from a longer piece by Mannasseh Phiri originally appearing in Zambia’s Sunday Post. Phiri is a long-time HIV prevention practitioner and advocate.

If you have ever heard me make a presentation on HIV and AIDS in Zambia in the last 10 years, you will know that I always start with a picture of a magnificent specimen of a bull elephant standing in its majesty on the banks of the mighty Zambezi. As I show the picture I tell the story of how the African elephant in many ways behaves like HIV—quietly consuming a huge amount of resources.

I was thinking about how I seriously need to rehash, freshen or renew my own presentations’ opening story about the similarity the African elephant to the virus HIV [when I was reminded of] a piece of African wisdom that I hadn’t heard since I was child. “When ants are well organised, they can kill an elephant”. HIV/AIDS is a giant elephant and if we the people organise ourselves well, like ants, we can conquer HIV!

I was recently holed up in hotel in Johannesburg with other ‘ants’—feeding off each other’s energy, enthusiasm, sense of purpose, conviction and determination that the end for this elephant is possible and can be achieved. For this meeting [the AVAC Partners’ Forum] the ants came from Kenya, Rwanda, South Africa, Uganda, Zambia and Zimbabwe—all of them researchers, advocates and activists—with the combined power to make a whole herd of elephants scamper in fear.

It was not just the energy and enthusiasm of the “ants” that floored me. Their technical knowledge and understanding of the detailed intricacies and nuances of the research work they are doing made me ashamed of coming from Zambia. While cutting edge research in HIV prevention with oral antiretrovirals, vaginal and rectal gels, and vaginal rings is going on and advancing HIV science in Kenya, Uganda, Rwanda, Malawi, Zimbabwe and South Africa, Zambia is dithering with approvals because of suspicion.

I feel like the day is not far when I shall no longer need to always wear the AIDS red ribbon and the Until There’s A Cure copper bangle on my left wrist. Thanks to the meeting of the ants, the elephant’s days are numbered.

The Importance of Location and Population to the HIV Response

This graphic from AVAC’s Microbicides by the Numbers one-pager shows on which populations the burden of the epidemic falls in different regions.

Achieving the End

Recent breakthroughs in HIV prevention research have created unprecedented opportunities to curb new HIV infections, save lives and set the world on a path towards eliminating HIV transmission.

Reaching the Tipping Point: The time to act is now

AVAC Playbook 2012-2013: Progress toward global goals

AVAC first published its Playbook of global goals for ending AIDS in late 2011. This infographic from the AVAC Report 2012 builds on the objectives from 2011 and identifies five priorities for action in 2013.

Defining Combination Prevention: Ongoing trials in sub-Saharan Africa

The Change We Need to End AIDS in Uganda

2012 AVAC Fellow Alice Kayongo played a leading role in developing a civil society report, “The Change We Need to End AIDS in Uganda”, which details concerns and recommendations for shaping the national AIDS response in Uganda. This report was presented at the Joint Annual Review (JAR) of the country’s five-year National Strategic Plan (NSP) for responding to HIV/AIDS, which was first launched about a year ago. The mid-October JAR meeting was an opportunity to review progress and gaps. In the weeks leading up to the JAR, civil society participated in reviews of draft assessments of progress on the various elements of the NSP, including prevention, treatment and care, and health systems strengthening.

Kayongo was joined in this coalition effort by Sylvia Nakasi and Bharam Namanya of UNASO (2011 Fellow and Host Supervisor, respectively), and Leonard Okello, Alice’s Fellowship supervisor and Lillian Mworeko of ICW-EA (2012 Host)—as well as a broad range of other advocates.

The report, presented at the JAR, included a 10-point plan to halt new infections, save lives and ensure leadership, and provided a detailed critique of the national AIDS response to date.

This advocacy comes on the heels of a dynamic and successful campaign to increase funding for and recruitment of more than 6,000 health care workers throughout Uganda.

For a copy of the report, reach out to fellows@avac.org.

Promoting Combination Prevention Through Song

Remember prevention is better than cure,
Combination prevention will see us through
To conquer this infection, it needs you;
An AIDS free generation begins with you.

Last month 2012 AVAC Fellow Chamu Mashoko and a number of Zimbabwean musicians released “For You, I Will”. The song, which uses the message of taking care of yourself as a commitment to those you love to promote combination prevention, is part of Mashoko’s AVAC Advocacy Fellowship project.

To Mashoko, a song was an obvious way to spread this message. “Music is a universal language and among most Africans, important information is disseminated through music.” The song incorporates different styles of music and is performed in the three main spoken languages of Zimbabwe with the hope of furthering its appeal. It is the latest entry into the Zimbabwean HIV prevention songbook. In July 2012 a trio of famous musicians from Africa, including Oliver Mtukudzi and Winky Dee of Zimbabwe and Vee from Botswana, released a song on voluntary medical male circumcision at the International AIDS Conference.

Since its release, Mashoko and his collaborators have been interviewed on radio and in print and people have expressed an interest in a music video.

Click to listen to “For You, I Will” and read the lyrics.

For you, I’m really going to get HIV tested!
Take all the measures that will prevent us from being infected.
And let’s encourage everybody who is affected,
They need to feel respected and not to be rejected.

Click here to listen.

Press Release

AVAC statement on PEPFAR Blueprint

New York, NY – PEPFAR’s blueprint has enormous potential to accelerate global HIV prevention efforts. It rightly emphasizes that we need to ‘follow the science’ if we intend to deliver life-saving HIV prevention and treatment breakthroughs to millions of people worldwide. The blueprint underscores that success depends on scaling up combinations of effective strategies. It also places much-needed emphasis on voluntary medical male circumcision, which could prevent millions of HIV infections and do so more affordably than almost any other method today.

It’s particularly encouraging that the blueprint focuses on translating scientific breakthroughs into lives saved. Powerful new HIV prevention options could together lead to dramatic reductions in HIV infections, but we don’t have all the information we need to scale them up in the right combinations for various communities. Urgent questions about the real-world use of new prevention tools in combination have been clear for months or even years, yet the work to answer them is barely under way. That’s as unconscionable as it is unnecessary.

The blueprint also recognizes that ending AIDS will not be easy or quick. While current options can have a tremendous impact, continued science and innovation are essential to ultimately halt new HIV infections and deaths from AIDS.

The US has shown great leadership, and now it’s time for the rest of the global community to step up. Frankly, we are not on pace to end AIDS – but we could be. Global agencies, governments, donors and advocates need to work with PEPFAR now to agree on the most urgent priorities, set specific goals and demonstrate real progress within the next year.

A PDF version of this is available for download.

Contact:

Mitchell Warren, mitchell@avac.org, +1-914-661-1536

###

About AVAC: Founded in 1995, AVAC is a non-profit organization that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of AIDS vaccines, male circumcision, microbicides, PrEP and other emerging HIV prevention options as part of a comprehensive response to the pandemic.